Suppr超能文献

用于开发扁球形可吸入粉末的大麻二酚与羟丙基-β-环糊精

Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder.

作者信息

Santos Gomes Bernardo Filipe, Bya Laure-Anne, Koch Nathan, Cabral-Marques Helena, Evrard Brigitte, Lechanteur Anna

机构信息

Laboratory of Pharmaceutical Technology and Biopharmacy, CIRM, University of Liège, 4000, Liège, Belgium.

Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisbon, Portugal.

出版信息

AAPS J. 2025 Jan 17;27(1):30. doi: 10.1208/s12248-025-01015-y.

Abstract

In addition to the known therapeutic indications for cannabidiol, its administration by inhalation appears to be of great interest. Indeed, there is evidence of cannabidiol's efficacy in several physiological pathways, suggesting its potential for a wide range of applications for both local and systemic pulmonary administration like cancers. Significant advances in pulmonary drug delivery have led to innovative strategies to address the challenges of increasing the respirable fraction of drugs and standardizing inhalable products. Among different devices, dry powder inhalers offer significant advantages including high stability and ease of use. Particle engineering using techniques such as spray drying is now the focus of research and is expected to improve upon, rather than completely replace, traditional carrier-based formulations. The development of carrier-free powders (without lactose-carrier) is mainly used for medicines with low active ingredient doses, which limits the technology. Previously, we demonstrated the benefits of using a cyclodextrin to obtain deflated spherical-shaped powders by spray drying. In this study the potential of this excipient with a very poorly water-soluble active molecule was investigated. Inhalable cannabidiol powders were developed by spray drying, using the solubility enhancers hydroxypropyl-beta-cyclodextrin and ethanol to optimize cannabidiol water-solubility. Electron microscopy images revealed consistent deflated spherical shapes, while particle size analysis showed low polydispersity and suitable sizes for deep lung deposition (2 µm). The selected engineered powders (without ethanol) had very high fine particle fractions (> 60%) due to their deflated surface. Finally, the powder was instantly solubilized leading to drug dissolution, which is important for therapeutic efficacy. In conclusion, this study successfully develops a cannabidiol inhalation powder by particle engineering having suitable aerosolization behavior. Due to the speed of the process and the performance of the finished product, this work opens the door for future studies. It has been shown that active molecules that are only slightly soluble in water can be formulated effectively as a powder for inhalation. Other molecules could be tested and subsequent in vivo studies conducted to demonstrate correlation with these in vitro results.

摘要

除了已知的大麻二酚治疗适应症外,通过吸入方式给药似乎也备受关注。事实上,有证据表明大麻二酚在多种生理途径中具有疗效,这表明其在局部和全身肺部给药(如癌症治疗)的广泛应用中具有潜力。肺部药物递送的重大进展带来了创新策略,以应对增加药物可吸入部分和使可吸入产品标准化的挑战。在不同的装置中,干粉吸入器具有显著优势,包括高稳定性和易用性。使用喷雾干燥等技术进行颗粒工程目前是研究的重点,预计会改进而非完全取代传统载体剂型。无载体粉末(无乳糖载体)的开发主要用于活性成分剂量低的药物,这限制了该技术的应用。此前,我们证明了使用环糊精通过喷雾干燥获得瘪球形粉末的益处。在本研究中,对这种辅料与水溶性极差的活性分子的潜力进行了研究。通过喷雾干燥,使用溶解度增强剂羟丙基-β-环糊精和乙醇来优化大麻二酚的水溶性,从而开发出可吸入的大麻二酚粉末。电子显微镜图像显示出一致的瘪球形,而粒度分析表明多分散性低且尺寸适合肺部深部沉积(2微米)。所选的工程粉末(无乙醇)由于其瘪表面具有非常高的细颗粒分数(>60%)。最后,粉末立即溶解导致药物溶解,这对治疗效果很重要。总之,本研究通过颗粒工程成功开发出具有合适雾化行为的大麻二酚吸入粉末。由于该过程的速度和成品的性能,这项工作为未来的研究打开了大门。已经表明,仅微溶于水的活性分子可以有效地制成吸入粉末。可以测试其他分子,并进行后续的体内研究以证明与这些体外结果的相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验